Agilent Technologies, Inc. (A)

NYSE · Health Care · Diagnostics & Research
By Alex · Tickerpine
$148.24
-1.25 (-0.84%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$41.87B
P/E (TTM)
29.8
Forward P/E
22.4
EPS (TTM)
$4.98
ROE
21.33%
Profit Margin
19.55%
Revenue Growth
10.00%
Dividend Yield
0.69%
Beta
1.23
52W High
$160.27
52W Low
$108.35
Analyst Target
$159.32

A stock forecast: what analysts expect

Consensus rating
Buy
Avg. 12-month target
$159.32
Implied upside
+7.5%

Wall Street analysts covering Agilent Technologies, Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $159.32 — +7.5% versus the last price of $148.24. Targets reflect analyst opinion, not a guarantee.

What would an investment in A be worth today?
Run A through our free historical return calculator.
Calculate A returns →

A historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year +18.9% +18.9% $1,189
3 years +25.3% +7.8% $1,253
5 years -12.5% -2.6% $875
10 years +241% +13.1% $3,413
20 years +674% +10.8% $7,744
Since 1999 +490% +6.9% $5,903

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in A.

A annual returns by year

2026 YTD +9.6%
2025 +1.9%
2024 -2.7%
2023 -6.4%
2022 -5.5%
2021 +35.5%
2020 +39.8%
2019 +27.5%
2018 +1.7%
2017 +48.3%

Congress trading in A

7 members of Congress have disclosed trading A — 5 purchases and 5 sales worth an estimated $129,000. Most recent disclosure: Sep 23, 2025.

See who in Congress traded A →

Insider activity in A

A's own executives and directors have made 0 open-market purchases ($0) and 1 sale ($216,672) in the last 90 days, per SEC Form 4 filings. Most recent: May 29, 2026.

May 29, 2026Dolsten Mikael Director Sell $216,672

About Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Company website ↗

A Key Statistics

Previous Close$149.49P/E Ratio29.8
Market Cap$41.87BPEG Ratio1.32
Revenue (TTM)$7.23BROE21.33%
Gross Margin52.64%ROA8.61%
Debt / Equity49.7Employees18,000

A in plain English

A stock: frequently asked questions

What is Agilent Technologies, Inc.'s stock price today?

Agilent Technologies, Inc. (A) last traded at $148.24 on the NYSE. Over the past 52 weeks the stock has traded between $108.35 and $160.27.

Is A stock a buy or a sell?

Wall Street analysts' consensus rating on A is "Buy", with an average 12-month price target of $159.32 — about +7.5% versus the current price of $148.24. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in A 10 years ago be worth today?

A $1,000 investment in Agilent Technologies, Inc. made 10 years ago would be worth about $3,413 today (dividends reinvested) — a total return of 241%, or 13.1% per year.

Does A pay a dividend?

Yes. Agilent Technologies, Inc. currently pays a dividend yielding about 0.69% per year at today's share price.

What is A's P/E ratio?

A trades at a trailing price-to-earnings ratio of 29.8, and 22.4 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade A stock?

Yes — 7 members of Congress have disclosed trades in A under the STOCK Act, totaling 5 purchases and 5 sales worth an estimated $129,000.

What is Agilent Technologies, Inc.'s ticker symbol?

Agilent Technologies, Inc. trades under the ticker symbol A on the NYSE.

Compare A with peers

A vs LLYEli Lilly and Company $1,220.28 A vs JNJJohnson & Johnson $260.86 A vs ABBVAbbVie Inc. $248.76 A vs UNHUnitedHealth Group Incorporated $405.59 A vs MRKMerck & Company, Inc. $132.92

Data last refreshed from public sources. Figures may be delayed. Not investment advice.